INOINOVIO PHARMACEUTICALS, INC.

Nasdaq inovio.com


$ 10.12 $ -0.04 (-0.34 %)    

Thursday, 25-Apr-2024 15:59:53 EDT
QQQ $ 430.17 $ -2.06 (-0.48 %)
DIA $ 380.88 $ -3.52 (-0.92 %)
SPY $ 507.81 $ -1.92 (-0.38 %)
TLT $ 87.78 $ -0.62 (-0.7 %)
GLD $ 215.92 $ 1.28 (0.6 %)
$ 10.125
$ 9.81
$ 0.00 x 0
$ 0.00 x 0
$ 9.79 - $ 10.12
$ 3.89 - $ 14.75
154,617
na
224.51M
$ 0.88
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-06-2024 12-31-2023 10-K
2 11-09-2023 09-30-2023 10-Q
3 08-09-2023 06-30-2023 10-Q
4 05-10-2023 03-31-2023 10-Q
5 03-01-2023 12-31-2022 10-K
6 11-08-2022 09-30-2022 10-Q
7 08-09-2022 06-30-2022 10-Q
8 05-10-2022 03-31-2022 10-Q
9 03-01-2022 12-31-2021 10-K
10 11-09-2021 09-30-2021 10-Q
11 08-09-2021 06-30-2021 10-Q
12 05-10-2021 03-31-2021 10-Q
13 03-01-2021 12-31-2020 10-K
14 11-09-2020 09-30-2020 10-Q
15 08-10-2020 06-30-2020 10-Q
16 05-11-2020 03-31-2020 10-Q
17 03-12-2020 12-31-2019 10-K
18 11-12-2019 09-30-2019 10-Q
19 08-08-2019 06-30-2019 10-Q
20 05-09-2019 03-31-2019 10-Q
21 03-12-2019 12-31-2018 10-K
22 11-08-2018 09-30-2018 10-Q
23 08-07-2018 06-30-2018 10-Q
24 05-09-2018 03-31-2018 10-Q
25 03-14-2018 12-31-2017 10-K
26 11-08-2017 09-30-2017 10-Q
27 08-08-2017 06-30-2017 10-Q
28 05-10-2017 03-31-2017 10-Q
29 03-15-2017 12-31-2016 10-K
30 11-09-2016 09-30-2016 10-Q
31 08-08-2016 06-30-2016 10-Q
32 05-09-2016 03-31-2016 10-Q
33 03-14-2016 12-31-2015 10-K
34 11-09-2015 09-30-2015 10-Q
35 08-10-2015 06-30-2015 10-Q
36 05-11-2015 03-31-2015 10-Q
37 03-16-2015 12-31-2014 10-K
38 11-10-2014 09-30-2014 10-Q
39 08-11-2014 06-30-2014 10-Q
40 05-12-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-skillsoft-shares-are-trading-lower-by-around-27-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter...

 inovio-pharmaceuticals-stock-is-diving-today-whats-happening

Inovio announced the pricing of an underwritten offering of 2,536,258 shares of its common stock at an offering price of $7.693...

 why-macatawa-bank-shares-are-trading-higher-by-around-37-here-are-20-stocks-moving-premarket

Shares of Macatawa Bank Corporation (NASDAQ: MCBC) rose sharply in today’s pre-market trading after Wintrust Financial Corpora...

 live-nation-entertainment-groupon-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session

U.S. stock futures were mixed this morning, with the Dow futures gaining around 100 points on Tuesday.

 reported-earlier-inovio-prices-36m-underwritten-offering-of-2536258-common-stock-at-7693share

INOVIO Pharmaceuticals announced the pricing of an underwritten offering of 2,536,258 shares of its common stock at an offering...

Core News & Articles

https://twitter.com/DrTedros/status/1778423967105139108  

 oppenheimer-maintains-outperform-on-inovio-pharmaceuticals-maintains-40-price-target

Oppenheimer analyst Hartaj Singh maintains Inovio Pharmaceuticals (NASDAQ:INO) with a Outperform and maintains $40 price tar...

 rbc-capital-reiterates-sector-perform-on-inovio-pharmaceuticals-maintains-11-price-target

RBC Capital analyst Gregory Renza reiterates Inovio Pharmaceuticals (NASDAQ:INO) with a Sector Perform and maintains $11 pri...

 victorias-secret-inovio-pharmaceuticals-broadcom-aptorum-group-tesla-why-these-5-stocks-are-on-investors-radars-today

Wednesday: Dow up 0.2% at 38,661.05, S&P 500 up 0.5% to 5,104.76, Nasdaq up 0.6% at 16,031.54.

 inovio-pharmaceuticals-q4-2023-gaap-eps-1100-beats-1270-estimate-sales-103000k-miss-344200k-estimate

Inovio Pharmaceuticals (NASDAQ:INO) reported quarterly losses of $(1.100) per share which beat the analyst consensus estimate o...

 earnings-scheduled-for-march-6-2024

Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue o...

 oppenheimer-upgrades-inovio-pharmaceuticals-to-outperform-announces-4-price-target

Oppenheimer analyst Hartaj Singh upgrades Inovio Pharmaceuticals (NASDAQ:INO) from Perform to Outperform and announces $4 pr...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION